160 related articles for article (PubMed ID: 38285369)
1. Cell-Free DNA and Next-Generation Sequencing for Prenatal Diagnosis.
Rieneck K
Methods Mol Biol; 2024; 2753():583-609. PubMed ID: 38285369
[TBL] [Abstract][Full Text] [Related]
2. Next Generation Sequencing-Based Fetal ABO Blood Group Prediction by Analysis of Cell-Free DNA from Maternal Plasma.
Rieneck K; Egeberg Hother C; Clausen FB; Jakobsen MA; Bergholt T; Hellmuth E; Grønbeck L; Dziegiel MH
Transfus Med Hemother; 2020 Feb; 47(1):45-53. PubMed ID: 32110193
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Antenatal Determination of Fetal Blood Group Using Next-Generation Sequencing.
Rieneck K; Clausen FB; Dziegiel MH
Cold Spring Harb Perspect Med; 2015 Oct; 6(1):a023093. PubMed ID: 26511760
[TBL] [Abstract][Full Text] [Related]
4. Prediction of fetal blood group and platelet antigens from maternal plasma using next-generation sequencing.
Orzińska A; Guz K; Mikula M; Kluska A; Balabas A; Ostrowski J; Uhrynowska M; Kopeć I; Dębska M; Luterek K; Brojer E
Transfusion; 2019 Mar; 59(3):1102-1107. PubMed ID: 30620409
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
Hyland CA; O'Brien H; Flower RL; Gardener GJ
Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
[TBL] [Abstract][Full Text] [Related]
6. Detection of fetal trisomy and single gene disease by massively parallel sequencing of extracellular vesicle DNA in maternal plasma: a proof-of-concept validation.
Zhang W; Lu S; Pu D; Zhang H; Yang L; Zeng P; Su F; Chen Z; Guo M; Gu Y; Luo Y; Hu H; Lu Y; Chen F; Gao Y
BMC Med Genomics; 2019 Nov; 12(1):151. PubMed ID: 31684971
[TBL] [Abstract][Full Text] [Related]
7. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
8. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Prenatal Diagnosis of Beta-Thalassemia Disease by Using Digital PCR Analysis of Cell-Free Fetal DNA in Maternal Plasma.
Charoenkwan P; Traisrisilp K; Sirichotiyakul S; Phusua A; Sanguansermsri T; Tongsong T
Fetal Diagn Ther; 2022; 49(11-12):468-478. PubMed ID: 36574763
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive prenatal diagnosis and screening for monogenic disorders.
Scotchman E; Shaw J; Paternoster B; Chandler N; Chitty LS
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():320-327. PubMed ID: 32907778
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province].
Liu X; LE F; Wang LH; Shu J; Xu XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):215-220. PubMed ID: 36765502
[TBL] [Abstract][Full Text] [Related]
12. Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma.
Ho SS; Barrett A; Thadani H; Asibal CL; Koay ES; Choolani M
Clin Chem Lab Med; 2015 Jul; 53(8):1189-95. PubMed ID: 25581758
[TBL] [Abstract][Full Text] [Related]
13. Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.
Alshehri AA; Jackson DE
Transfus Med Rev; 2021 Apr; 35(2):85-94. PubMed ID: 33781630
[TBL] [Abstract][Full Text] [Related]
14. Haplotype-Assisted Noninvasive Prenatal Diagnosis of Genetic Diseases by Massively Parallel Sequencing of Maternal Plasma Cell-Free DNA.
Ju J; Su F; Chen C; Sun J; Gao Y
Methods Mol Biol; 2023; 2590():287-294. PubMed ID: 36335505
[TBL] [Abstract][Full Text] [Related]
15. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies.
Brison N; Van Den Bogaert K; Dehaspe L; van den Oever JM; Janssens K; Blaumeiser B; Peeters H; Van Esch H; Van Buggenhout G; Vogels A; de Ravel T; Legius E; Devriendt K; Vermeesch JR
Genet Med; 2017 Mar; 19(3):306-313. PubMed ID: 27584908
[TBL] [Abstract][Full Text] [Related]
16. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model.
Stowell SR; Henry KL; Smith NH; Hudson KE; Halverson GR; Park JC; Bennett AM; Girard-Pierce KR; Arthur CM; Bunting ST; Zimring JC; Hendrickson JE
Blood; 2013 Aug; 122(8):1494-504. PubMed ID: 23801629
[TBL] [Abstract][Full Text] [Related]
17. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications.
Avent ND; Madgett TE; Maddocks DG; Soothill PW
Curr Opin Obstet Gynecol; 2009 Apr; 21(2):175-9. PubMed ID: 19262379
[TBL] [Abstract][Full Text] [Related]
18. Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fy
Alford B; Landry BP; Hou S; Bower X; Bueno AM; Chen D; Husic B; Cantonwine DE; McElrath TF; Carozza JA; Wynn J; Hoskovec J; Gray KJ
Sci Rep; 2023 Aug; 13(1):12786. PubMed ID: 37550335
[TBL] [Abstract][Full Text] [Related]
19. Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care.
Clausen FB
Prenat Diagn; 2014 May; 34(5):409-15. PubMed ID: 24431264
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of alloantibodies associated with haemolytic disease of the fetus and newborn in pregnant women at the Ekiti State University Teaching Hospital, Ado-Ekiti, Southwest Nigeria.
Olayanju AO; Chris NI; Emmanuel AE; Oyetunde AB; Adebisi KY; Okolo CS
Afr J Reprod Health; 2023 Jun; 27(6s):70-78. PubMed ID: 37694704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
